ABSTRACT To document the expansion of human babesiosis in Connecticut, we analyzed reservoir host sera for seroreactivity to Babesia microti Franca and reviewed Connecticut human surveillance case data collected during 2001Ð2010. Sera from white-footed mice, Peromyscus leucopus RaÞnesque, from 10 towns in 5 counties, collected at 4 Ð7-yr periods between 2001 and 2010, were tested for total immunoglobulins. The prevalence of B. microti-positive mice was compared with conÞrmed and probable human case reports tabulated by the Connecticut Department of Public Health. The highest babesiosis and rodent seroprevalence rates were in New London County, where this protozoan disease was Þrst documented in the state. However, human cases and reservoir host infection increased signiÞcantly from 2001Ð2005 to 2005Ð2010 and in other parts of the state. Clinicians should be aware that the disease is not conÞned to long-established endemic areas of the state.
Human babesiosis in the northeastern United States is caused by the rodent protozoan parasite Babesia microti Franca, which is usually transmitted through the bite of the blacklegged tick, Ixodes scapularis Say. The disease is also transmissible congenitally and through blood transfusion (Vannier and Krause 2012) . Babesiosis has long been endemic in several coastal areas in the northeastern United States, particularly parts of Long Island, New York, Rhode Island, and islands off of Cape Cod, Massachusetts (Spielman et al. 1981) . However, the number and distribution of reported human cases of babesiosis in the region have noticeably increased over the past 2 decades since the Þrst reported human cases in Stonington, CT, in 1988 ([CDC] Centers for Disease Control 1989), inland New Jersey in 1993 (Herwaldt et al. 2003) , and the Lower Hudson River Valley, New York, in 2001 (Kogut et al. 2005) . The number of reported cases in the Lower Hudson River Valley increased 20-fold from 2001 through 2008, and cases have also been reported from eastern Pennsylvania (Joseph et al. 2011 , Perez Acosta et al. 2013 . Those most susceptible to babesiosis are the elderly, immunocompromised, and people who lack a functioning spleen (Homer et al. 2000 , Krause 2002 . A recent analysis of babesiosis in Medicare beneÞciaries in the United States from 2006 to 2008 found that 10 states and the District of Columbia accounted for 83.3 to 84.7% of all cases, with the highest rates among the elderly in the known endemic states of Connecticut, Rhode Island, New York, and Massachusetts (Menis et al. 2012) .
The white-footed mouse, Peromyscus leucopus RaÞnesque, is the principal rodent reservoir for B. microti in the northeastern United States. Seropositivity rates to B. microti in this animal in endemic areas can be high (Stafford et al. 1999 , Magnarelli et al. 2013 . The prevalence of this pathogen is correlated with higher tick densities (Mather et al. 1996) . In 1999, human seroprevalence and parasitemia in blood donors in Connecticut were signiÞcantly higher in an endemic county than in a county considered nonendemic (Leiby et al. 2005) . In this study, we compared the reported incidence of human babesiosis over the 10-yr period from 2001 to 2010 with serological evidence of antibodies to B. microti in P. leucopus in endemic and emerging areas of Connecticut.
Materials and Methods
Surveillance for Babesiosis. Human babesiosis was made a physician-reportable disease to the Connecticut Department of Public Health (CTÐDPH) in October 1989, and laboratory-reportable in January 1990. During the study period, a conÞrmed case was deÞned as identiÞcation of the parasite within red blood cells on a peripheral blood smear or by polymerase chain reaction (PCR) testing of whole blood, while a probable case was based on positive serological test results with the identiÞcation of antibodies to B. microti with a titer of 1:256 or higher . The number of conÞrmed and probable case reports was combined, and the incidence per 100,000 population was determined by year, town, and county. The number of conÞrmed babesiosis cases for the 169 towns in Connecticut is available on the CTÐDPH Web site (www.ct.gov/dph). The 2000 population census data for Connecticut were used to calculate the rate for 2001 through 2009, and the 2010 census Þgures were used for 2010. To simplify tabulation, the human case data were summarized for the periods 2001Ð2005, 2006 Ð2010, and the entire 10-yr period. Babesiosis was made nationally reportable in January 2011 (Herwaldt et al. 2012) . National statistics are tabulated at the county level.
Study Areas. Mice were live-trapped at varying periods and locations from April or June through August 2001Ð2010. Trap sites were located on both private and public property in 10 towns located in Þve of ConnecticutÕs eight counties (Table 1) . A total of 2,787 rodents were captured over 12,466 trap nights (one trap night equals one trap placed overnight), which represented 1,822 individual P. leucopus and 318 recaptures. From 2001 to 2003, trapping was conducted in the Mumford Cove (MC) community of Groton and at a residence in Old Lyme, New London County in association with a white-tailed deer, Odocoileus virginianus, reduction study (Kilpatrick and LaBonte 2003, Dolan et al. 2004 ). The MC community of 112 homes consisted of Ϸ38.8 ha of residential development and Ϸ41.3 ha of undeveloped woodland area in MC proper. Trapping was conducted at both treated and untreated home sites and adjacent woodland areas.
During 2001Ð2006, there were 5Ð10 and 5Ð12 mousetrapped properties in the towns of Weston and Westport, respectively, in FairÞeld County. Similarly, in LitchÞeld County, mice were trapped during 2002Ð 2007 at 4Ϫ13 home properties each in the three towns of Salisbury, Canaan, and Cornwall (Table 1) . These residential properties varied in size and landscape characteristics, but all had lawn bordered by mixed deciduous forest, and little understory vegetation due to over-browsing by white-tailed deer. Stone walls were also found on many of the properties. Only untreated sites related to some tick management stud- (Williams et al. 2009, Williams and Ward 2010) . Many of these areas had moderate to heavy stands of mature Japanese barberry, Berberis thunbergii de Candolle, which was shown to provide habitat conducive to higher tick densities (Williams et al. 2009, Williams and Ward 2010) . Data for each habitat type for each location were pooled for the purposes of this study.
Mouse Sampling. Peromyscus were captured using rigid or folding Sherman box traps (H.B. Sherman Traps Inc., Tallahassee, FL) baited with peanut butter and/or apple. Mice were anesthetized with methoxyßurane or isoßurane, received a numbered ear tag (National Band and Tag, Newport, KY), examined for ticks, and a blood sample was collected by cardiac puncture (0.1Ð 0.2 ml) under protocols for limited biweekly (or longer period) sampling approved by The Connecticut Agricultural Experiment StationÕs Institutional Animal Care and Use Committee. Serum was obtained after centrifugation of clotted blood samples at 5,000 ϫ g for 5 min and stored at Ϫ60ЊC until antibody analyses were conducted. Mice were released at the site of capture upon recovery from anesthesia. Total captures included P. leucopus and, in LitchÞeld County, the deer mouse, Peromyscus maniculatus LeConte, but the deer mouse data were not included in the Þnal analysis.
Serological Assays. Indirect ßuorescent antibody staining methods were used to detect total immunoglobulins to B. microti. Sera from laboratory-reared P. leucopus were used as negative controls. Antigen of B. microti consisted of infected erythrocytes obtained from Golden Syrian hamsters (Mesocricetus auratus) and whole blood from an infected person diagnosed a Total captures include both P. leucopus and the deer mouse, P. maniculatus. The deer mouse was not included in the analyses as shown in Table 3. with human babesiosis (Anderson et al. 1991, Anderson and Magnarelli 2004) . Details on the source of the ßuorescein-conjugated antibodies and antigen preparation have been previously described (Anderson et al. 1991 , Magnarelli et al. 1997 . Reactivity of infected erythrocytes is considered positive for antibodies to B. microti at a serum dilution of Ն1:80. Therefore, for the purposes of this study, prevalence of infection with B. microti means prevalence of B. microti antibody-positive mice. A total of 1,529 blood samples from P. leucopus, tested for reactivity to B. microti, were used for the analyses. Multiple positive results from an individual mouse captured more than once was only counted as positive once.
Statistical Analysis. With the human incidence data and proportion of infected mice meeting normality and equal variance requirements, a two-way ANOVA was used to examine both the incidence of babesiosis and prevalence of the mice seropositive for B. microti by year and county with means separation by the HolmÐSidack method (Systat Software Inc. 2008, SigmaPlot version 11, Systat Software Inc., San Jose, CA). Although there were different trapping intervals at different locations, overall differences in disease incidence between the Þrst half (2001Ð2005) and second half (2006 Ð2010) of the 10-yr period were compared with a StudentÕs t-test. The z-test on proportions was used to compare the prevalence of infection in P. leucopus between the two 5-yr periods and speciÞc counties.
Results
Human Babesiosis. The number of human babesiosis cases reported in Connecticut generally increased over the 10-yr period from 2001 to 2010 (Fig. 1 Table 2 ). The greatest number of babesiosis cases was reported in 2008 (n ϭ 333; Fig. 1 ). Case-patients ranged from 0 (2 Ͻ 1 yr of age) to 100 yr in age with a mean age of 56.6 (Ϯ0.46) yr (n ϭ 1,684). Of the 1,699 cases, 710 were female, 927 were male, with 62 for which gender was unknown. A slight majority were conÞrmed cases, diagnosed by positive blood smear (51%) or PCR (2%), while 47% were diagnosed by serology and classiÞed as a probable case. Nearly half (49%) were positive by combined PCR and serology.
Cases of babesiosis were reported in residents from 148 (87.6%) of ConnecticutÕs primary 169 towns, and all eight counties ( Fig. 2a and b) . For 8.2% of the cases, the county was unknown (Table 2) . During the study period, the incidence of disease differed signiÞcantly by year (F ϭ 90.201; df ϭ 9; P Յ 0.001) and county (F ϭ 46.192; df ϭ 7; P Յ 0.001). New London County had a signiÞcantly (HolmÐSidaki multiple comparison; t ϭ 8.67Ð14.536; all P Յ 0.001) higher incidence of disease than all other counties with a mean of 24.21 cases per 100,000 population, and accounted for 37.1% of the total number of case reports (Table 2) . Unlike the period from 1991 through 2002 , there was no distinct increasing trend (annual county data not shown), possibly reßecting the endemicity of babesiosis in the area. Nevertheless, there was a signiÞcant (one-sample t-test, t ϭ 6.550; df ϭ 5; P ϭ 0.001) annual ßuctuation in disease incidence in the county during the same period (Table 3) apparently due to a high proportion of probable cases, and decreased in 2009 and 2010 (Fig. 1) . Counties adjacent to New London County, Windham and Middlesex, had the second and third highest incidence, respectively, during the study period. Although Windham County showed the greatest increase (3.5ϫ) in incidence from the Þrst half to the second half of the study period, LitchÞeld County experienced a signiÞcant (t ϭ Ϫ3.911; df ϭ 8; P ϭ 0.004) nearly sixfold increase in incidence between the 5-yr periods (Table 2) . Combined rates from New London, Windham, and Middlesex counties were signiÞcantly higher than those in the two western counties (t ϭ 3.804 Ð 4.520; P Յ 0.001). Central New Haven and Hartford counties had the lowest incidence of human babesiosis. There was no signiÞcant difference in disease incidence between Windham, Tolland, LitchÞeld, and FairÞeld counties (P Ͼ 0.05). The inci- dence of human babesiosis in LitchÞeld County increased during the period from 2002 to 2007 (0.0 Ð7.7 cases per 100,000 population), although the difference was not signiÞcant (t ϭ 2.152; df ϭ 5; P ϭ 0.0840; Table  3 ). However, there was a signiÞcant difference in the incidence of human babesiosis across the entire study period of 2001Ð2010 (t ϭ 3.676, df ϭ 8, P ϭ 0.006).
There was a doubling of human disease incidence in FairÞeld County from 2.18 to 4.62 cases per 100,000 population (Table 2) . Prevalence in White-Footed Mice. During the study period, there was no signiÞcant annual difference (P Ͼ 0.05) in the prevalence of Babesia infection in mice, but the difference between counties was highly signiÞcant (F ϭ 22.969; df ϭ 4; P Յ 0.001). The prevalence of antibodies to B. microti in P. leucopus trapped in New London County from 2001 to 2006 was relatively high, with 61.4% of 166 mice testing positive for B. microti (Table 3) , a proportion similar to that found in 1997 (76.9% of 26 mice; z ϭ 1.301; P ϭ 0.191; Stafford et al. 1999 ). In addition, the difference in the prevalence of infection between the Þrst sample years (i.e., 2002Ð2004) and the subsequent 2-yr interval was virtually the same (61.5 vs. 60.9%, respectively; z ϭ Ϫ0.176; P ϭ 0.860). In New Haven County, the prevalence of Babesia reactivity in the mice was relatively high (74.4% of 313 mice; Table 3 ; Fig. 2b; Fig. 3) , and the proportion of seropositive P. leucopus in New Haven County was slightly greater than in New London County (61.4%).
Babesia seroprevalence in FairÞeld County was also relatively high, at least during the last 4 yr of trapping, and showed a signiÞcant (z ϭ 8.061; P Յ 0.001) increase in the proportion of infected mice during the entire study period. FairÞeld County was the only county for which mouse trap data were available from 2001 through 2010. The seroprevalence for B. microti in white-footed mice in FairÞeld County was not signiÞcantly (z ϭ 0.180; P ϭ 0.857) different from that detected in 1997. Nevertheless, there was a signiÞcant difference in the proportion of infected animals in FairÞeld County between 1997 and the more recent 2006 Ð2010 period (z ϭ 2.871; P ϭ 0.004). Examining the annual data from Table 3 across the same 5-yr intervals for which the disease incidence was tabulated, we Þnd that the proportion of antibody-positive mice increased from 11.4 to 49.2%.
More notably, the increase in seroprevalence in P. leucopus in LitchÞeld County was highly signiÞcant (z ϭ 3.938; P Յ 0.001) between the period 2002Ð2003 (7.6%), when there were no reported human cases, and the subsequent 4-yr period (2004 Ð2007 
Discussion
The number of cases of human babesiosis reported to the Connecticut Department of Public Health increased by over Þvefold between 2001 and 2008, especially in some areas of the state, although cases subsequently dropped by nearly half in 2009 and 2010. This may be due, in part, to lower tick abundance during 2010 (K.C.S., unpublished data), which was also reßected in 29% fewer conÞrmed Lyme disease cases in Connecticut when compared with the previous year (Ertel et al. 2011 ). The number of cases reported in this study also represented another Þve-fold increase from the 10-yr period from 1991 to 2000, when only 296 cases were reported to the CTÐDPH (Cartter and Ertel 2001) . While babesiosis is no longer a coastal, mainly southeastern concern, Windham and Tolland counties had the third and fourth highest incidence of human infection, with the majority of cases still reported in residents of New London County. LitchÞeld County showed a nearly sixfold increase in incidence between the 5-yr periods, again demonstrating the expansion of disease. Similarly, there were signiÞcant increases or levels in the seroprevalence of antibodies to B. microti in the mice in FairÞeld, LitchÞeld, and Tolland counties. Clearly, the incidence of human disease and evidence of infection in the reservoir host have expanded to other areas of the state.
Human risk is reßected by recovery of the pathogen in earlier Connecticut studies, reported cases of human disease, human seroprevalence studies, and the presence of the parasite, as measured by serological reactivity, in the Peromyscus reservoir host in this study. While children and adults often experience symptomatic disease, some people infected with B. microti are asymptomatic (Krause et al. 2003) . Like any tick-associated disease, the number of reported human babesiosis cases might be inßuenced by a number of factors, such as tick abundance, infectivity rates, peopleÕs activity levels (exposure), media attention, surveillance methods and physician reporting, number of blood transfusions in the case of babesiosis, and the clinical information needed for conÞrmation. One of the principal factors for ßuctuations in reported Lyme disease cases has been changes in surveillance method over time (Ertel et al. 2012) , although this isnÕt the case for babesiosis in Connecticut. However, human incidence of babesiosis was high in the coastal and eastern counties, where we detected high B. microti seroprevalence in reservoir mice. Additional evidence that B. microti is prevalent in rodents in coastal Connecticut has been provided by the recovery and isolation in inoculated laboratory hamsters of the protozoan parasite from mice in New London and FairÞeld counties (Anderson et al. 1991, Anderson and Magnarelli 2004) . Similarly, Johnson et al. (2009) found that Middlesex and New London counties had signiÞcantly higher human seroprevalence rates for babesiosis than all other counties among sampled blood donors; there were seropositive donations from residents in all eight Connecticut counties.
In contrast to a general pattern of increased reservoir infection and corresponding human infection, New Haven County had the highest proportion of mice testing positive for antibodies to B. microti, yet had the second lowest incidence (1.4 cases per 100,000 population) in the state. This may be attributable, in part, to the largely urban and suburban population of New Haven County and partly to the rural, forested landscape of the study site that may be more characteristic of many areas of Middlesex County, where disease incidence was relatively high (12.71 cases per 100,000 population) during the same period. Increased forest density was associated with increased risk of babesiosis in the state of New York, but the largest forest patch areas were not associated with babesiosis (Walsh 2013) . As already noted, the North Branford property had moderate to heavy stands of mature Japanese barberry, Berberis thunbergii, which provides habitat conducive to higher tick densities (Williams et al. 2009, Williams and Ward 2010) , but it is not a residential area and public access is restricted. In addition, the New London data were collected earlier than those from New Haven County. Unlike Tolland County, this study was limited by the lack of reservoir host data for Windham and Middlesex counties and tick prevalence data. It is unclear how many of the apparent differences are due to differences between sites rather than changes through time. Additional studies may show a high prevalence of the parasite in both the reservoir host and tick in Windham County. The seroprevalence for B. microti in the mice at the Tolland County site was similar to that of the other emerging areas of the state, that is, FairÞeld and LitchÞeld counties. However, the proportion of mice with antibodies to B. microti in recaptured mice from a subset from this study in 2007 and 2008 was generally high in New Haven County (range, 81Ð 84%) but lower (range, 15Ð33%) in Tolland County (Magnarelli et al. 2013) .
The distribution of human babesiosis remains geographically more constrained than that of Lyme disease, where some of the highest rates in Connecticut over the past decade have been in LitchÞeld County . While the incidence of babesiosis has increased in the northwest region of the state, it appears less than that reported for the neighboring Duchess County, NY. In the Lower Hudson River Valley, human babesiosis increased from Ϸ2.9 cases per 100,000 during 2001Ð2005 to Ϸ16.9 cases per 100,000 during 2006 Ð2008 (Joseph et al. 2011) , a rate comparable with that observed in some areas of Connecticut but still higher than reported for the adjacent LitchÞeld County. There were 1,610 human cases of babesiosis in New York (not including New York City) from 2000 to 2010, a number similar to the 10-yr period of this study in Connecticut. Nevertheless, the significant increase in B. microti antibodies and evidence of infection in the mice in LitchÞeld County should provide for increased transmission to I. scapularis, resulting in increased human disease. New London County in the southeastern corner of the state still had the highest number of reported cases and documented incidence of human babesiosis, as well as a high rate of infection in the P. leucopus reservoir based on seropositivity to B. microti.
National surveillance for human babesiosis began in 18 states and 1 city in January 2011, and 97% of the 1,124 conÞrmed and probable cases were from 7 states (Connecticut, Massachusetts, Minnesota, New Jersey, New York [including New York City], Rhode Island, and Wisconsin; Herwaldt et al. 2012) . Connecticut accounted for only 6.6% of the reported cases, reßect-ing expansion of the disease through the northeastern United States However, human babesiosis is underreported and the true incidence in some endemic areas may be closer to that of the more prevalent Lyme disease (Krause et al. 2003) . In Connecticut, serological screening from endemic (southeastern) and nonendemic (north central) areas of the state in 1999 revealed that of the 1,745 human blood samples, 1.4 and 0.3%, respectively, were conÞrmed as positive for antibodies to B. microti (Leiby et al. 2005) . In the Lyme region of New London County, we found that reactivity of P. leucopus sera to the Lyme disease spirochete, Borrelia burgdorferi, was identical to that for B. microti in the mice (76.9% of 26 mice; Stafford et al. 1999) . This again suggests that the proportion of Babesia-infected reservoir mice has been relatively constant in the southeastern portion of the state since at least the late 1990s, which contributes to the greater incidence of human disease in New London County. In the adjacent Rhode Island, the potential risk for human babesiosis was greatest along the coast where B. microti is present and nymphal tick densities for I. scapularis are high (Mather et al. 1996) . The possible reasons for the slow expansion of human babesiosis relative to Lyme disease in the state are multifold and may include the following: tick infection rates with B. microti are generally lower than those of Borrelia burgdorferi and may require greater tick abundance for transmission, the number of Babesia delivered by a feeding tick (Mather et al. 1990) , the establishment and prevalence of infection in the reservoir host, and the more limited reservoir host dispersal capabilities. Babesiosis was not detected in Connecticut until 1988, a decade after Lyme disease. In contrast, during the same period, there were 32,911 reported conÞrmed or probable Lyme disease cases, for which I. scapularis is also the principal vector.
There are many factors in the emergence of infectious disease (Smolinski et al. 2003) , but the emergence of Lyme disease (and therefore to a similar extent, that of babesiosis) has been related to reforestation and an increase of white-tailed deer (Barbour and Fish 1993) . More speciÞcally, the emergence of human babesisosis, like any zoonotic, vector-borne disease, is a result of the prevalence of infection in reservoir species, the sufÞcient presence of vectors, and adequate humanÐvector interaction to result in infection. Human cases, infected reservoir animals, and I. scapularis have been identiÞed throughout Connecticut. Babesiosis is highly endemic in southeastern and coastal areas but still appears to be an emerging, even endemic, albeit still increasing, infectious disease in northern and western regions of the state. Clinicians should consider babesiosis in their diagnoses of persons demonstrating appropriate clinical symptoms with potential exposure to ticks, and be aware that the disease is not conÞned to long-established endemic or coastal areas of the state.
